Genetically engineered 'Magneto' protein remotely controls brain and behavior

>An investigation by Moderna, Rovi and Takeda Pharmaceutical Co., which is in charge of the vaccine’s distribution in Japan, is ongoing. The foreign material is “a metal that reacts to a magnet” and is believed to have entered the vials during the production process, the Asahi Shimbun quoted an unidentified senior health ministry official as saying.